Lower Urinary Tract Symptoms Screening Questionnaire (LUTS-2)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
St. Michael's Hospital, Toronto
ClinicalTrials.gov Identifier:
NCT01616810
First received: August 26, 2011
Last updated: June 8, 2012
Last verified: June 2012
  Purpose

The purpose of this study is to determine the validity of a screening tool which has been designed to detect the presence or absence of lower urinary tract symptoms in the general female population.


Condition
Cystocele

Study Type: Observational
Official Title: Lower Urinary Tract Symptoms Screening Questionnaire Validation STudy

Resource links provided by NLM:


Further study details as provided by St. Michael's Hospital, Toronto:

Primary Outcome Measures:
  • Presence or absence of lower urinary tract symptoms in the general female population [ Time Frame: Five years ] [ Designated as safety issue: No ]
    To validate the effectiveness of a screening tool in detecting the presence or absence of lower urinary tract symptoms in the general female population.


Enrollment: 300
Study Start Date: January 2007
Study Completion Date: December 2011
Primary Completion Date: October 2007 (Final data collection date for primary outcome measure)
Groups/Cohorts
observation
Healthy participants

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Healthy participants, 18 years of age and older with any gynecological symptoms other than lower urinary tract symptoms or pelvic floor dysfunction

Criteria

Inclusion Criteria:

  • Healthy participants, 18 years of age and older with any gynecological symptoms

Exclusion Criteria:

  • Patients with lower urinary tract symptoms and pelvic floor dysfunction
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01616810

Sponsors and Collaborators
St. Michael's Hospital, Toronto
Investigators
Principal Investigator: Dana Soroka, MD, FRCS(C) St. Michael's Hospital, Toronto
  More Information

No publications provided

Responsible Party: St. Michael's Hospital, Toronto
ClinicalTrials.gov Identifier: NCT01616810     History of Changes
Other Study ID Numbers: REB 04-227C
Study First Received: August 26, 2011
Last Updated: June 8, 2012
Health Authority: Canada: Ethics Review Committee

Keywords provided by St. Michael's Hospital, Toronto:
urinary tract

Additional relevant MeSH terms:
Cystocele
Urinary Bladder Diseases
Urologic Diseases
Pelvic Organ Prolapse
Prolapse
Pathological Conditions, Anatomical

ClinicalTrials.gov processed this record on April 15, 2014